| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Cocero Nanette | Director | C/O HILLEVAX, INC.,, 321 HARRISON AVE, SUITE 500, BOSTON | /s/ Paul Bavier, Attorney-in-Fact for Nanette Cocero | 2025-06-25 | 0001976937 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLVX | Common Stock | Award | $0 | +17.2K | $0.00 | 17.2K | Jun 23, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The Restricted Stock Units ("RSUs") were granted on June 23, 2025 pursuant to the Registrant's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (i) the first anniversary of the date of grant or (ii) a Change in Control (as defined in the Registrant's 2022 Incentive Award Plan), in each case, subject to the non-employee director continuing in service on the Registrant's board of directors through such vesting date. |